• search
For Quick Alerts
ALLOW NOTIFICATIONS  
For Daily Alerts

CoviFind: ICMR approves Meril’s Covid-19 self-testing kit that can deliver accurate results in 15 minutes

|

New Delhi, Jun 10: Medtech firm Meril on Thursday said it has received approval from the Indian Council of Medical Research (ICMR) for its self-use rapid antigen test kit for COVID-19.

The company''s indigenous home-use rapid antigen test kits ''CoviFind'' will expand access to COVID-19 testing, while also helping the nation meet the demand for increased and frequent screening to curb the spread of the pandemic, Meril said in a statement.

CoviFind: ICMR approves Meril’s Covid-19 self-testing kit that can deliver accurate results in 15 minutes

The test delivers results swiftly, providing accurate results in 15 minutes, it added.

"By making reliable rapid antigen testing available to all through a convenient format, Meril''s CoviFind test will facilitate early detection, isolation, treatment and contact tracing," Meril Senior Vice-President (Corporate Strategy) Sanjeev Bhatt said.

The test kit is equipped with testing materials including a test device, one sterile nasal swab and a pre-filled buffer tube with a cap and is priced at Rs 250 as an affordable single-pack, the company said.

The test kits will be available in two weeks at retail pharmacies, e-pharmacies and through e-commerce platforms including Amazon and Flipkart, it added.

Meril said it has also supplied a large number of tests across its COVID-19 diagnostics offerings across India, which include a multiplex RT-PCR test, Kavach antibody tests in partnership with ICMR.

For Daily Alerts
Get Instant News Updates
Enable
x
Notification Settings X
Time Settings
Done
Clear Notification X
Do you want to clear all the notifications from your inbox?
Settings X
X